In this interactive town hall, KHI members and partners discussed eligibility criteria, enrollment practices and trial design to enhance the diversity of clinical trials. Viewers will hear from a diverse group of representatives ranging from FDA to people living with kidney disease on the guidance and implementation of this important topic. A copy of this presentation can be found here.